Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, June 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ('Olema” or 'Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical...